We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$49.5B
AUM Growth
+$2.3B
Cap. Flow
+$776M
Cap. Flow %
1.57%
Top 10 Hldgs %
36.27%
Holding
973
New
103
Increased
264
Reduced
443
Closed
98

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$803M
2
CL icon
Colgate-Palmolive
CL
+$626M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$152M
4
ORCL icon
Oracle
ORCL
+$140M
5
YUMC icon
Yum China
YUMC
+$98M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.63%
2 Technology 16.85%
3 Financials 11.99%
4 Healthcare 11.92%
5 Communication Services 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOR
751
DELISTED
STORE Capital Corporation
STOR
$11K ﹤0.01%
418
+177
+73% +$4.59K
ALX
752
Alexander's
ALX
$1.41B
$10K ﹤0.01%
+26
New +$10.1K
ENTA icon
753
Enanta Pharmaceuticals
ENTA
$400M
$10K ﹤0.01%
90
NTCT icon
754
NETSCOUT
NTCT
$2.79B
$10K ﹤0.01%
323
-1,010
-76% -$28.1K
RDNT icon
755
RadNet
RDNT
$5.69B
$10K ﹤0.01%
653
POLY
756
DELISTED
Plantronics, Inc.
POLY
$10K ﹤0.01%
131
-164
-56% -$11.3K
CCMP
757
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$10K ﹤0.01%
90
ARI
758
Apollo Commercial Real Estate
ARI
$885M
$9K ﹤0.01%
468
+8
+2% +$147
CRL icon
759
Charles River Laboratories
CRL
$12.8B
$9K ﹤0.01%
78
-184
-70% -$19.9K
DIOD icon
760
Diodes
DIOD
$4.84B
$9K ﹤0.01%
248
-786
-76% -$25.9K
FULT icon
761
Fulton Financial
FULT
$4.64B
$9K ﹤0.01%
534
+44
+9% +$763
GMED icon
762
Globus Medical
GMED
$11.2B
$9K ﹤0.01%
182
-24
-12% -$1.25K
LPX icon
763
Louisiana-Pacific
LPX
$5.49B
$9K ﹤0.01%
343
-24
-7% -$691
MC icon
764
Moelis & Co
MC
$4.94B
$9K ﹤0.01%
156
-15
-9% -$862
MMI icon
765
Marcus & Millichap
MMI
$1.19B
$9K ﹤0.01%
221
MYGN icon
766
Myriad Genetics
MYGN
$312M
$9K ﹤0.01%
238
+7
+3% +$236
PLUS icon
767
ePlus
PLUS
$2.34B
$9K ﹤0.01%
184
-20
-10% -$873
RGEN icon
768
Repligen
RGEN
$9.25B
$9K ﹤0.01%
197
+15
+8% +$617
SANM icon
769
Sanmina
SANM
$10.9B
$9K ﹤0.01%
308
-979
-76% -$28.8K
SEM
770
DELISTED
Select Medical
SEM
$9K ﹤0.01%
870
SYNA icon
771
Synaptics
SYNA
$4.15B
$9K ﹤0.01%
186
+13
+8% +$590
TTMI icon
772
TTM Technologies
TTMI
$14.5B
$9K ﹤0.01%
521
-1,650
-76% -$27.6K
WAFD icon
773
WaFd
WAFD
$2.75B
$9K ﹤0.01%
+285
New +$9.37K
YELP icon
774
Yelp
YELP
$1.41B
$9K ﹤0.01%
+227
New +$9.82K
NUVA
775
DELISTED
NuVasive, Inc.
NUVA
$9K ﹤0.01%
180
-557
-76% -$29.2K

Similar funds

Loomis, Sayles & Company's Q2 2018 Portfolio in Review

As of Q2 2018, Loomis, Sayles & Company held 973 positions worth $49.5B, up 4.9% from $47.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loomis, Sayles & Company's Q2 2018 filing shows 103 new, 264 increased, 443 reduced and 98 closed positions. Its largest new stake was NVR: 8,693 shares worth $25.8M. The largest sale was Cisco, an estimated $457M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Loomis, Sayles & Company's largest Q2 2018 buy was NVR: 8,693 shares worth $25.8M.
  • Loomis, Sayles & Company added most to Starbucks in Q2 2018, an estimated $803M increase.
  • Loomis, Sayles & Company's biggest Q2 2018 reduction was Cisco, cutting an estimated $457M.
  • Loomis, Sayles & Company fully exited Callidus Software, Inc. in Q2 2018, selling an estimated $31.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 36% of its $49.5B portfolio in Q2 2018.
  • Loomis, Sayles & Company opened 103 new positions and closed 98 in Q2 2018.
  • Loomis, Sayles & Company's portfolio value rose 4.9% quarter-over-quarter to $49.5B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2018, filed 14 Aug 2018.